FDA-Approved Bionic Eye Implant Enters Broad Testing in US
The FDA has granted approval for the Argus II Retinal Prosthesis System, created by Second Sight, which is set to undergo extensive trials at 12 clinics across the United States. This innovative 'bionic eye' is intended for patients suffering from advanced retinitis pigmentosa (RP). The system features a camera mounted on glasses that sends images to 60 electrodes situated in the retina, enabling users to perceive images in shades of black, white, and grey at a resolution of approximately 60 pixels wide. While initial testing has shown limited success, other retinal implant technologies are being investigated worldwide, such as nanowire systems at UC-San Diego and chip designs by NanoRetina. Additionally, DIY enthusiasts like Rich Lee are exploring sensory enhancement through embedded magnets for sound, highlighting a growing interest in augmentation beyond traditional medical approaches.
Key facts
- Argus II Retinal Prosthesis System approved by FDA in February 2013
- Developed by Second Sight
- Targets patients with late-stage retinitis pigmentosa
- System includes camera on glasses and 60-electrode grid implanted at back of retina
- Wireless transmission from camera to electrodes stimulates healthy retinal nerves
- Perceived images are black, white, and grey at roughly 60 pixels' width
- Entering broad testing at 12 American clinics
- Alternative approaches: UC-San Diego (nanowires), NanoRetina (chip), German-Hungarian team (different routes)
- Rich Lee inserted rare-earth magnets into ears for sound reception
- Lee plans to add more magnets and connect to mics and apps
Entities
Artists
- Rich Lee
Institutions
- Second Sight
- UC-San Diego
- NanoRetina
- FDA
Locations
- United States
- Israel
- Germany
- Hungary
Sources
- Quartz —